[Antithrombogenic therapy based on the study of the changes in platelet aggregability and blood coagulability in the early period after prosthetic valve replacement].
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D001777:Blood Coagulation; D004176:Dipyridamole / Q000008:administration & dosage*; D005260:Female; D006349:Heart Valve Diseases / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation; D011183:Postoperative Complications / Q000517:prevention & control; D013876:Thiophenes / Q000008:administration & dosage*; D013927:Thrombosis / Q000517:prevention & control*; D013988:Ticlopidine; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D013876:Thiophenes; D014859:Warfarin; D004176:Dipyridamole; D013988:Ticlopidine